WebbHER2 in AGC The ToGA trial enrolled only HER2-positive patients following central assessment of HER2. Two FDA-approved methods are currently used to assess HER2 … Webb10 nov. 2014 · Efficacy Results from the ToGA Trial: A Phase III Study of Trastuzumab Added to Standard Chemotherapy (CT) in First-Line Human Epidermal Growth Factor …
Nghiên cứu sự biểu lộ HER2 ở bệnh nhân ung thư dạ dày
Webb24 okt. 2013 · Harry H. Yoon, MD, MHS. Assistant Professor, Division of Medical Oncology, Mayo Clinic, Rochester, MN;[email protected] Abstract. Determination of HER2 status has become an important part of the workup of patients with advanced esophagogastric cancer, given recent data from a phase III trial (ToGA) indicating that trastuzumab, an … WebbHER2 expression varies by tumor location and type. All patients with advanced gastric or gastroesophageal junction cancer should be tested for HER2 status, preferably using … glass stove tops pros and cons
2024版CSCO胃癌诊疗指南转移性胃癌更新解读_参考网
WebbTrastuzumab (anti-HER2 antibody) Trastuzumab is a monoclonal antibody targeting HER2. In 2010, ToGA trial [phase III, including EGJ (n = 106) and advanced gastric adenocarcinoma (n = 478)] was to assess the efficacy and safety of trastuzumab plus first-line chemotherapy (XP or FP) of advanced HER2 positive 106 EGJ and 478 gastric … Webb8 feb. 2016 · The ToGA study showed that trastuzumab plus chemotherapy prolonged median survival in patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer. Among chemotherapy options, oxaliplatin might be as effective as cisplatin but has shown to be more tolerable. Webb1 juni 2024 · 二、her2 分子靶点与靶 ... toga是一项多中心的Ⅲ期随机对照试验,评估曲妥珠单抗联合化疗(卡培他滨联合顺铂或氟尿嘧啶联合顺铂)用于her-2阳性的食管腺癌或胃癌。594例患者按照1:1随机分别入组单纯化疗组和联合靶向治疗组。 glass straight tube bong uk